Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2021 / Cilt: 26 - Sayı: 4

Factors Effecting COVID-19 Vaccine Refusal andHesitation After Initiation of National VaccinationProgram in Turkey

Türkiye’de Ulusal Aşı Programının Başlatılması Sonrası COVID-19 Aşı Reddive Tereddütünü Etkileyen Faktörler

Pages
610–619
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Concern about the vaccines was themost important risk factor for vaccine hesitancy and refusal.Conclusion: Our study suggested that vaccine hesitancy was related to lower education level, and negative concern about the vaccine.Vaccine refusal was related to history of COVID-19 infection, negative concern on the vaccine, non-healthcare occupation, and higherlevel of death anxiety scale.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Safe and effective prophylactic vaccines are needed to control rapidly advancing COVID-19, which has devastatingmedical, economic, and social consequences.
📊
Key Findings & Data:This study aimed to identify factors associated with COVID-19 vaccine rejection and hesitation after initi ation of the national vaccination program.
💡
Conclusion & Impact:Concern about the vaccines was themost important risk factor for vaccine hesitancy and refusal.Conclusion: Our study suggested that vaccine hesitancy was related to lower education level, and negative concern about the vaccine.Vaccine refusal was related to history of COVID-19 infection, negative concern on the vaccine, non-healthcare occupation, and higherlevel of death anxiety scale.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Safe and effective prophylactic vaccines are needed to control rapidly advancing COVID-19, which has devastatingmedical, economic, and social consequences. It is believed that one of the most critical obstacles to vaccination activities is negativeattitudes towards vaccines. This study aimed to identify factors associated with COVID-19 vaccine rejection and hesitation after initi ation of the national vaccination program. Materials and Methods: The study was conducted using an online questionnaire. Participants’ socio-demographic and clinical dataand COVID-19 outbreak experiences, attitudes towards the vaccine of COVID-19 were collected through a specially designed structuredquestionnaire. The participants were also asked to complete Death Anxiety Scale (DAS) and Health Anxiety Scale (HAS). Multiple logisticregression analyses were performed to reveal the factors predicting vaccine hesitancy and rejection. Results: A total of 1,546 completed responses were received. Vaccine hesitation and refusal rates were 8.9% and 9%, respectively.Older age, high education level and lower concern on the vaccine was observed in participants that accepted vaccination compared topatients who refused and hesitated vaccination. High education levels and healthcare workers had decreased risk of vaccine hesitancy.High Death Anxiety Score and being a healthcare worker had decreased risk for vaccine refusal. Concern about the vaccines was themost important risk factor for vaccine hesitancy and refusal.Conclusion: Our study suggested that vaccine hesitancy was related to lower education level, and negative concern about the vaccine.Vaccine refusal was related to history of COVID-19 infection, negative concern on the vaccine, non-healthcare occupation, and higherlevel of death anxiety scale.

Özet

Giriş: Olumsuz tıbbi, ekonomik ve sosyal sonuçları olan hızla ilerleyen COVID-19 pandemisini kontrol etmek için güvenli ve etkili profilaktikaşılara ihtiyaç vardır. Aşı faaliyetlerinin önündeki en kritik engellerden birinin aşılara yönelik olumsuz tutumlar olduğu düşünülmektedir.Bu çalışma, ulusal aşı programının başlatılmasından sonra COVID-19 aşı reddi ve tereddüt ile ilişkili faktörleri belirlemeyi amaçlamaktadır. Materyal ve Metod: Çalışma, çevrimiçi bir anket kullanılarak yürütüldü. Katılımcıların sosyo-demografik, klinik verileri, COVID-19pandemi deneyimleri ve COVID-19 aşısına yönelik tutumları özel olarak tasarlanmış yapılandırılmış bir anket aracılığıyla toplandı.Katılımcılardan ayrıca Ölüm Kaygısı Ölçeği (DAS) ve Sağlık Kaygısı Ölçeği’ni (HAS) doldurmaları istendi. Aşı tereddüt ve reddini öngörenfaktörleri ortaya koymak amacıyla lojistik regresyon analizleri yapıldı. Bulgular: Toplam 1.546 tamamlanmış yanıt alındı. Aşı tereddüt ve red oranları sırasıyla %8.9 ve %9 idi. Aşıyı kabul edenlerin, aşıyıreddeden ve tereddüt edenlere göre yaş ve eğitim düzeylerinin yüksek ve aşıya yönelik endişelerinin daha az olduğu görüldü. Eğitimseviyesi yüksek olanlarda ve sağlık çalışanlarında aşı tereddütü daha düşüktü. Yüksek Ölüm Kaygısı Skoru ve sağlık çalışanı olmak aşıreddi riskini azalttı. Aşılarla ilgili endişe, aşı tereddütü ve reddi için en önemli risk faktörüydü. Sonuç: Çalışmamız, aşı tereddütünün düşük eğitim düzeyi ve aşılara yönelik endişe ile ilişkili olduğunu düşündürmektedir. Aşı reddi, COVID 19 infeksiyonu öyküsü, aşılara yönelik endişe, yüksek düzey ölüm kaygısına sahip olma ve sağlık çalışanı olmama durumu ile ilişkiliydi.

🔖

Cite This Article

ÜNAL, G. Ö., ÖZYÜREK, S. E., ÜNAL, O. (2022). Factors Effecting COVID-19 Vaccine Refusal andHesitation After Initiation of National VaccinationProgram in Turkey. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 26 - Sayı: 4, 610–619. https://ajindex.com/articles/517099

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. World Health Organization (WHO). Coronavirus (COVID-19) Dashboard [cited 2021 30.06.2021]. Available from:
  2. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395(10239):1763-70
  3. T.C. Sağlık Bakanlığı COVID-19 Aşısı Bilgilendirme Platformu. Accessed date: 30.06.2021. Available from: https:// covid19asi.saglik.gov.tr/
  4. Guzman-Holst A, DeAntonio R, Prado-Cohrs D, Juliao P. Barriers to vaccination in Latin America: A systematic literature review. Vaccine 2020;38(3):470-81
  5. Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health 2020;16(1):57
  6. Akca F, Kose A. Adaptation of death anxiety scale (DAS): validity and reliability studies. Journal of Clinical Psychiatry 2008;11:7-16
  7. Templer DI. The construction and validation of a Death Anxiety Scale. J Gen Psychol. 1970;82(2d Half):165-77
  8. Aydemir O, Kirpinar I, Sati T, Uykur B, Cengisiz C. Reliability and Validity of the Turkish Version of the Health Anxiety Inventory. Noro Psikiyatr Ars 2013;50(4):325-31
  9. Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002;32(5):843-53
  10. Alberts NM, Hadjistavropoulos HD, Jones SL, Sharpe D. The Short Health Anxiety Inventory: a systematic review and meta-analysis. J Anxiety Disord 2013;27(1):68-78
  11. Rode S, Salkovskis P, Dowd H, Hanna M. Health anxiety levels in chronic pain clinic attenders. J Psychosom Res 2006;60(2):155-61
  12. Alabdulla M, Reagu SM, Al-Khal A, Elzain M, Jones RM. COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population. Influenza Other Respir Viruses 2021 May;15(3):361-70
  13. Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med 2020:1-3
  14. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARSCoV-2 Vaccine: A Survey of U.S. Adults. Ann Intern Med 2020;173(12):964-73
  15. Paul E, Steptoe A, Fancourt D. Att